Cognitive flexibility as a target for relapse prevention
认知灵活性作为预防复发的目标
基本信息
- 批准号:10165417
- 负责人:
- 金额:$ 34.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptive BehaviorsAgonistAlcohol abuseAnteriorBehaviorBehavior TherapyBehavioralBrainBrain regionChronicCognitiveCuesDevelopmentEthanolExposure toFamilyFemaleFoodGoalsHabitsHeavy DrinkingHippocampus (Brain)ImpairmentIndividualInjectionsLeadLearningMaintenanceMedialMemoryModelingNicotineNicotinic AgonistsNicotinic ReceptorsOutcomePharmaceutical PreparationsPharmacologyPsychological reinforcementRattusRecording of previous eventsRecoveryRelapseResistanceSpeedStimulusThalamic structureTimeTrainingalcohol availabilityalcohol effectalcohol exposurealcohol seeking behaviorcholinergiccholinergic neuroncingulate cortexcognitive enhancementcostcritical perioddisorder later incidence preventiondrinkingepibatidineflexibilityimprovedinnovationmaleneurotransmissionpreventproblem drinkerreceptorresponsesexside effecttherapy outcome
项目摘要
Abstract
Recovery involves replacing drinking with more adaptive behavior. Once the more adaptive behavior
becomes habitual, recovery is more resistant to relapse produced by stimuli previously occasioning
drinking. However, until this transition occurs, the new adaptive behavior is easily displaced. This
transition requires cognitive flexibility in order to attend to the stimuli and contingencies associated
with the new behavior. Unfortunately, heavy drinking reduces cognitive flexibility, especially in
females. This reduced cognitive flexibility appears to result from reduced cholinergic activity at α4β2
and α7 nicotinic receptors, particularly those in the hippocampus and anterior cingulate innervated by
cholinergic neurons originating in the medial septum. Restoring cholinergic function may restore
cognitive flexibility during the new learning involved in transitioning from habitual drinking to more
adaptive habits; and thus, speed this transition. Speeding this transition minimizes the most fragile
period of recovery, the early stages before new habits have developed. However, increasing
cholinergic function above an optimal level impairs new learning. Thus, enhancing cholinergic
function may only speed recovery when chronic drinking has reduced cognitive flexibility, perhaps
more so in females. We explore these possibilities using a rat model of recovery we developed. Like
in the real world, in this model high and low levels of drinking are controlled not by changing ethanol
availability, but rather by changing the contingencies governing the availability of alternatives, in this
case food. In the presence of one stimulus, food is costly and drinking predominates. In the presence
of another, food is easily available and little drinking occurs, simulating recovery. After several
consecutive recovery sessions in which rats only encounter low cost food conditions, presenting the
high-cost food stimulus no longer controls responding for ethanol. Instead rats persist at responding
for food, indicating this response has become habitual and control by the high-cost food stimulus has
weakened. We propose examining whether chronic intermittent ethanol exposure slows the
development of recovery, and whether this effect is greater in females. Further, we compare effects of
nicotine to those of epibatidine and PNU-282987, which preferentially activate α4β2 and α7 receptors,
respectively. Finally, we examine effects of delivering nicotine into the hippocampus and cingulate and
compare these to those following administration into the thalamus (not expected to influence cognitive
flexibility). This project explores an innovative target for relapse prevention: medications intended to
speed new habit formation, such as might occur during behavioral therapy. This strategy may
reduce relapse during the early, critical period of recovery, thus improving therapeutic outcomes.
摘要
康复包括用更适应的行为取代饮酒。一旦更适应的行为
养成习惯,康复对先前引起的刺激所产生的复发更具抵抗力
喝酒。然而,在这种转变发生之前,新的自适应行为很容易被取代。这
过渡需要认知上的灵活性,以便处理相关的刺激和意外情况
有了新的行为。不幸的是,大量饮酒会降低认知灵活性,尤其是在
女性。这种认知灵活性的降低似乎是由于α4β2胆碱能活动减少所致
和α7烟碱受体,特别是海马区和前扣带回的受体。
胆碱能神经元起源于内侧隔。恢复胆碱能功能可能会恢复
新学习中的认知灵活性涉及从习惯饮酒到更多饮酒的转变
适应习惯;因此,加快了这一转变。加速这一转变可以最大限度地减少最脆弱的人
恢复期,在新习惯形成之前的早期阶段。然而,越来越多的
胆碱能功能超过最佳水平会损害新的学习。因此,增强胆碱能
也许只有当长期饮酒降低了认知灵活性时,功能才会加速恢复
女性的情况更是如此。我们使用我们开发的大鼠恢复模型来探索这些可能性。喜欢
在现实世界中,在这个模型中,高水平和低水平的饮酒并不是通过改变酒精来控制的
而是通过改变管理替代方案可用性的偶然性,在这方面
箱子里的食物。在只有一种刺激措施的情况下,食品价格昂贵,饮酒占主导地位。当着大家的面
另一方面,食物很容易获得,很少喝水,模拟了康复。在经历了几次
在连续的恢复会议中,大鼠只遇到低成本的食物条件,呈现出
高成本的食品刺激不再控制对乙醇的反应。相反,老鼠坚持做出反应
对于食物,表明这种反应已经成为习惯,并受到高成本食物刺激的控制
被削弱了。我们建议研究慢性间歇性酒精暴露是否会减缓
恢复的发展,以及这种影响是否在女性中更大。此外,我们还比较了两种方法的效果
尼古丁与表巴替丁和PNU-282987相比,后者优先激活α4β2和α7受体,
分别进行了分析。最后,我们检查了尼古丁进入海马体和扣带回的效果。
将这些与丘脑给药后的结果进行比较(预计不会影响认知
灵活性)。该项目探索了预防复发的创新目标:旨在
加快新习惯的养成,比如在行为治疗期间可能会发生的情况。这一战略可能
在康复的早期关键时期减少复发,从而改善治疗结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRETT C GINSBURG其他文献
BRETT C GINSBURG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRETT C GINSBURG', 18)}}的其他基金
Cognitive flexibility as a target for relapse prevention
认知灵活性作为预防复发的目标
- 批准号:
10399580 - 财政年份:2018
- 资助金额:
$ 34.12万 - 项目类别:
Cognitive flexibility as a target for relapse prevention
认知灵活性作为预防复发的目标
- 批准号:
9922837 - 财政年份:2018
- 资助金额:
$ 34.12万 - 项目类别:
Attentional bias to alcohol cues in rats: development and decline
大鼠对酒精线索的注意偏差:发展和衰退
- 批准号:
8824070 - 财政年份:2015
- 资助金额:
$ 34.12万 - 项目类别:
Reinstatement of drug-maintained behavior suppressed by extinction or an availabl
恢复因灭绝或可用药物而抑制的药物维持行为
- 批准号:
8135608 - 财政年份:2008
- 资助金额:
$ 34.12万 - 项目类别:
Reinstatement of drug-maintained behavior suppressed by extinction or an availabl
恢复因灭绝或可用药物而抑制的药物维持行为
- 批准号:
7677487 - 财政年份:2008
- 资助金额:
$ 34.12万 - 项目类别:
Reinstatement of drug-maintained behavior suppressed by extinction or an availabl
恢复因灭绝或可用药物而抑制的药物维持行为
- 批准号:
7918899 - 财政年份:2008
- 资助金额:
$ 34.12万 - 项目类别:
Reinstatement of drug-maintained behavior suppressed by extinction or an availabl
恢复因灭绝或可用药物而抑制的药物维持行为
- 批准号:
7528749 - 财政年份:2008
- 资助金额:
$ 34.12万 - 项目类别:
Models for examining selective effects of pharmacotherapy on reinforced behaviors
检查药物治疗对强化行为的选择性影响的模型
- 批准号:
7424063 - 财政年份:2007
- 资助金额:
$ 34.12万 - 项目类别:
Age, ethanol, and strain effects on the behavioral pharmacology of cannabinoids
年龄、乙醇和应变对大麻素行为药理学的影响
- 批准号:
7209229 - 财政年份:2007
- 资助金额:
$ 34.12万 - 项目类别:
Age, ethanol, and strain effects on the behavioral pharmacology of cannabinoids
年龄、乙醇和应变对大麻素行为药理学的影响
- 批准号:
7432571 - 财政年份:2007
- 资助金额:
$ 34.12万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 34.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 34.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)